Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about MERCK & CO., INC.
12/03FDA Approves Merck's KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Pedi..
BU
12/03Merck in Supply Agreement With Canada for Antiviral Medicine for Covid-19
DJ
12/03Merck Canada Announces Supply Agreement of Up to 1 Million Patient Courses of Molnupira..
AQ
12/03KYODO NEWS DIGEST : Dec. 3, 2021 -3-
AQ
12/03U.S. pharma Merck unit seeks Japan's approval of oral COVID drug
AQ
12/03Merck & Co. Said to Seek Japanese Regulatory Nod for COVID-19 Pill
MT
12/03Merck Applies for Covid Pill Approval in Japan, Nikkei Reports
DJ
12/03Tokyo stocks end higher on hopes for COVID-19 oral treatment drug
AQ
12/02U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for..
AQ
12/02Federal Court Of Appeal Dismisses Appeal, Upholds Strict Interpretation Of Patent Listi..
AQ
12/01Merck & Company's Supplemental Biologics License Application for Vaxneuvance Gets FDA P..
MT
12/01Merck Gets FDA Priority Review of Vaxneuvance Vaccine in Children
DJ
12/01U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for..
BU
12/01U.S. Food and Drug Administration Accepts for Priority Review the Supplemental Biologic..
CI
11/30US FDA Panel Recommends Merck & Co.'s COVID-19 Pill
MT
More most relevant news
All news about MERCK & CO., INC.
12/03FDA Approves Merck's KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Pedi..
BU
12/03Merck in Supply Agreement With Canada for Antiviral Medicine for Covid-19
DJ
12/03Merck Canada Announces Supply Agreement of Up to 1 Million Patient Courses of Molnupira..
AQ
12/03Canada Signs Deal for 1 Mln Doses of Pfizer Covid Antiviral and 500K Merck's Covid Pill
MT
12/03Bristol Myers Squibb Gets FDA Acceptance of sBLA for Reblozyl
DJ
12/03Bristol-Myers Squibb's Supplemental Biologics License Application for Drug Co-Developed..
MT
12/03KYODO NEWS DIGEST : Dec. 3, 2021 -3-
AQ
12/03Biotech Growth Stocks Set to Benefit from Rising Volatility (REGN, OTLC, AMGN, ILMN, LL..
AQ
12/03Nikkei 225 Gains 1% on Merck Covid-19 Drug Application
MT
12/03U.S. pharma Merck unit seeks Japan's approval of oral COVID drug
AQ
More news
News in other languages on MERCK & CO., INC.
12/03Merck & Co schließt Liefervereinbarung mit Kanada für Covid-19-Medikament
12/03MERCK : examen prioritaire de la FDA pour le reblozyl
12/03Le Nikkei 225 gagne 1 % grâce à la demande d'homologation du médicament Covid-19 de Mer..
12/03Merck & Co. Merck chercherait à obtenir l'aval des autorités japonaises pour la pilule ..
12/02CORONA-BLOG/Spahn sichert Deutschland Covid-Medikament Lagevrio von Merck
12/01MÄRKTE USA/Erster Omikron-Fall in den USA belastet die Wall Street
12/01MÄRKTE USA/Erholung - Berg- und Talfahrt geht weiter
12/01MÄRKTE USA/Festere Kurse zum Start - Börsen spielen wieder Entspannung
12/01MÄRKTE USA/Achterbahnfahrt geht wieder nach oben
12/01MERCK : examen prioritaire de la FDA sur le Vaxneuvance
More news
Analyst Recommendations on MERCK & CO., INC.
11/30ANALYST RECOMMENDATIONS : Best Buy, Beyond Meat, Booking, Merck, Pfizer...
11/29SVB Leerink Adjusts Merck & Co.'s Price Target to $102 from $105, Keeps Outperform Rati..
MT
11/29Morgan Stanley Adjusts Merck & Co.'s Price Target to $82 from $88, Keeps Equalweight Ra..
MT
11/29ANALYST RECOMMENDATIONS : Asos, Burberry, Greif, Merck, Mirion Technologies....
11/29Citigroup Cuts Merck & Co. to Neutral From Buy, Price Target to $85 From $105
MT
More recommendations
Press releases
12/03FDA Approves Merck's KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Pedi..
BU
12/03Merck Canada Announces Supply Agreement of Up to 1 Million Patient Courses of Molnupira..
AQ
12/03KYODO NEWS DIGEST : Dec. 3, 2021 -3-
AQ
12/03Biotech Growth Stocks Set to Benefit from Rising Volatility (REGN, OTLC, AMGN, ILMN, LL..
AQ
12/03U.S. pharma Merck unit seeks Japan's approval of oral COVID drug
AQ
More press releases
Upcoming event on MERCK & CO., INC.